ASPHALION´S NEW WEBSITE | Stage of development: preclinical

Introducing Asphalion´s new website and its different approaches to our services by stage of development. On this occasion, preclinical.

Introducing Asphalion´s new website and its different approaches to our services by stage of development. On this occasion, preclinical.
July 21, 2022

Did you know that…?

Our brand new web features a section called “SERVICES”. You can navigate through our services by choosing different approaches: by department, by stage of development, by product or by region. Today we are focusing on stage of development, more in detail on preclinical developments.

Prior to entering clinical trials to confirm the results obtained in preclinical research in humans, a product needs to be correctly defined to ensure the best regulatory strategy and clinical approach.

Facilitating a correct definition of the research development and regulatory plan, which involves proper designation of the product, will determine: timings, requirements during later phases, types of meetings to be carried out, the regulatory intermediaries that will be involved, and the possibility of accessing waivers and other mechanisms to accelerate approval that will depend on the medical need to be covered and the nature of the product.

Strategic regulatory inputs can be given from the very beginning for segmentation/niche indication, conditional approval/fast-track, orphan drug designations, and preclinical plans oriented for minimum time to market.

Asphalion can be the ideal regulatory partner during these early stages prior to proceeding to clinical research or in the very early stages of clinical research:

  • Ad hoc Regulatory advice and strategic consultancy during prodcut development
  • Support in early regulatory engagement with regulatory authorities including strategic and operative support during the meeting: preparation of Briefing Package, attendance to the meetings with authorities and adequation of the meeting content to comply with company plans
  • Regulatory partner for Horizon programmes

Have a look here for additional, more detailed information:

For further requests, you can send us an email at:

Search News & Events

  • Filter by category


Related news and events

EVENT | 20th Biosimilar Medicines Conference by MFE

During these two interactive days, actors of the healthcare community alongside world experts in biosimilar medicines will gather and debate the evolving biosimilar medicines landscape and emerging trends. Discussion will focus on sharing good practices and setting collective aims to achieve the depth, breadth and speed of the use of biosimilar medicines as a lever to untap their transformative value.

For further information

If you are interested in our services, or wish to get in touch for a general enquiry, please contact us for more information.

Fill the form and we will contact you as soon as possible.

You can also follow us on:

Schedule a Free Meeting

Schedule here a free 30-minutes meeting with one of our consultants and tell us about your project, challenges or doubts. 

We will be happy to assist you!

Schedule a meeting